Anti-viral therapeutic compositions
AssigneeCape Kingdom Nutraceuticals (Pty) Ltd
InventorMichael Duncombe STANDER
Life of this patent
Estimating the term…
Abstract
The invention discloses an anti-viral therapeutic composition, which includes at least one anti-viral active ingredient originating from an aqueous Buchu extract or bio-active fraction thereof in a pharmaceutically acceptable form. The composition can be a pharmaceutical composition including a therapeutically effective amount of at least one or more anti-viral active ingredient and one or more pharmaceutically acceptable carriers or additives. The aqueous Buchu extract is obtained from the species Agasthoma betulina (round-leaf Buchu) and/or Agathosma crenulata (oval-leaf Buchu).
Claims15
An anti-viral therapeutic composition, which includes at least one anti-viral active ingredient originating from an aqueous Buchu extract or bio-active fraction thereof in a pharmaceutically acceptable form.
A modified aqueous Buchu extract or bio-active fraction thereof, which includes an effective amount of one or more anti-viral active ingredients.
A therapeutic composition, pharmaceutical composition or modified aqueous Buchu extract or bio-active fraction thereof for use in a method of inducing an anti-viral response, in particular an anti-HIV response, in a mammal, preferably a human, in need thereof.
11-13. (canceled)
A method of treating a viral infection such as a HIV infection, which includes the step of administering to a patient in need thereof a therapeutically effective amount of at least one active ingredient obtained from an aqueous Buchu extract or bio-active fraction thereof.
17-22. (canceled)
Dependencies are inferred from the claim text.